Global Helicobacter Pylori Testing Market Size By Type (With Endoscopy, Without Endoscopy), By Application (Physical Examination Center, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

The Global Helicobacter Pylori (H. pylori) Testing Market was valued at USD 0.9 billion in 2023 and is projected to surpass USD 1.5 billion by 2031, growing at a CAGR of 6.1% during the forecast period from 2023 to 2031. The rising global prevalence of H. pylori infection, which is linked to serious gastrointestinal conditions such as gastritis, peptic ulcers, and gastric cancer, is a primary driver of market growth. As healthcare systems increasingly focus on early detection and non-invasive diagnostic solutions, the demand for H. pylori testing continues to expand, supported by advancements in diagnostic technologies and growing public awareness.

Drivers:

1. Increasing Prevalence of H. pylori Infection:

H. pylori is a major causative agent of chronic gastritis and gastric ulcers. According to global estimates, over 50% of the world population may be infected with this bacterium, highlighting the need for widespread and effective testing.

2. Technological Advancements in Diagnostic Tools:

The evolution of non-invasive and rapid testing methods such as urea breath tests, stool antigen tests, and serology has enhanced diagnostic accuracy and patient compliance, boosting adoption rates in both clinical and home settings.

3. Growing Awareness and Preventive Healthcare:

Public health campaigns and clinical initiatives focusing on gastrointestinal health have led to increased screening for H. pylori, particularly in high-risk populations. Early detection significantly reduces the risk of complications like gastric cancer.

Restraints:

1. Inconsistent Testing Access in Low-Income Regions:

Limited healthcare infrastructure and lack of awareness in developing economies can hinder the uptake of H. pylori testing, especially non-invasive methods that may not be readily available.

2. False Positives/Negatives in Serological Testing:

Some diagnostic methods, particularly antibody-based tests, may yield inaccurate results, leading to misdiagnosis or repeated testing, which affects reliability and patient confidence.

Opportunity:

1. Expansion of Home-Based and Point-of-Care Testing:

The demand for home testing kits and point-of-care solutions is on the rise due to convenience and faster turnaround times. Manufacturers investing in user-friendly test kits are expected to capitalize on this growing segment.

2. Emerging Markets and Untapped Regions:

Asia-Pacific, Latin America, and parts of Africa offer untapped potential due to the high burden of infection and ongoing improvements in healthcare infrastructure, diagnostics, and disease awareness.

Market by System Type Insights:

Among the different testing systems, the Urea Breath Test segment held the largest market share in 2023. Recognized for its high sensitivity and specificity, this non-invasive test is preferred in clinical settings for its accuracy and quick results. However, the Stool Antigen Test segment is expected to witness the fastest growth due to its suitability for pediatric patients and its increasing availability in home test kit formats.

Market by End-use Insights:

Based on end-use, the Hospitals and Diagnostic Laboratories segment emerged as the largest contributor in 2023, accounting for a significant portion of the revenue. These facilities perform large volumes of H. pylori tests, leveraging advanced laboratory infrastructure. Meanwhile, the Home Care Settings segment is expected to grow rapidly, driven by the availability of FDA-approved home testing kits and the shift toward personalized healthcare.

Market by Regional Insights:

North America dominated the market in 2023, attributed to advanced healthcare infrastructure, proactive screening initiatives, and higher awareness levels. However, Asia-Pacific is projected to witness the highest CAGR during the forecast period due to a higher infection burden, increasing healthcare spending, and a growing focus on preventive diagnostics in countries like China, India, and Japan.

Competitive Scenario:

Key players operating in the global H. pylori testing market include:

Thermo Fisher Scientific Inc.

Meridian Bioscience Inc.

QuidelOrtho Corporation

Sekisui Diagnostics LLC

DiaSorin S.p.A.

Bio-Rad Laboratories, Inc.

Abbott Laboratories

Roche Diagnostics

Cardinal Health

Exalenz Bioscience Ltd.

These companies are focusing on expanding their product portfolios, developing faster and more accurate diagnostic kits, and forming strategic partnerships with healthcare providers to strengthen their global market presence.

Scope of Work – Global Helicobacter Pylori Testing Market

Report Metric Details

Market Size (2023) USD 0.9 Billion

Projected Market Size (2031) USD 1.5 Billion

CAGR (2023–2031) 6.1%

Key Segments System Type (Urea Breath Test, Stool Antigen, Serology), End-Use (Hospitals, Diagnostic Labs, Home Care), Region

Growth Drivers Rising prevalence of H. pylori infection, technological advancements in diagnostics

Opportunities Home-based testing growth, emerging markets expansion

Key Market Developments:

2023: Abbott Laboratories launched a next-gen stool antigen test kit, optimized for self-use, targeting remote and underserved populations.

2024: QuidelOrtho expanded its product line with a new urea breath test system featuring Bluetooth-enabled breath analyzers for real-time diagnostics.

2025: Roche Diagnostics announced a strategic partnership with